Evidence map›Paper›PMID 42763855›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2027

Updated Protocols for 3D and 2D Culture and Histological Analysis of Intestinal Organoids.

Hikaru Hanyu, Shinya Sugimoto, Toshiro Sato

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hikaru HanyuDepartment of Integrated Medicine and Biochemistry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Shinya SugimotoDepartment of Integrated Medicine and Biochemistry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. sugimoto-kei@umin.ac.jp.
Toshiro SatoDepartment of Integrated Medicine and Biochemistry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. t.sato@keio.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intestinal epithelium maintains continuous self-renewal and multi-differentiation capacities through the integrated regulation of multiple signaling pathways, including Wnt, bone morphogenetic protein, epidermal growth factor (EGF), and Notch signaling pathways. Based on this principle, a defined combination of EGF, Noggin, and the Wnt agonist R-spondin has been shown to support long-term expansion of mouse intestinal stem cells and the formation of organoids with indefinite self-renewal and full differentiation capacity. In human intestinal organoid cultures, the addition of small molecule inhibitors targeting p38 and TGF-β pathways facilitated epithelial propagation, while replacement of EGF and a p38 inhibitor with insulin-like growth factor-1 and fibroblast growth factor-2 enabled efficient multilineage differentiation. Recently, the monolayer culture of intestinal organoid has been increasingly used due to its advantages of direct access to the apical membrane and its ability to co-culture with gut microbiota. Here, we summarize our recent technological advances in human intestinal organoid culture and histological analysis, providing updated protocols that will deepen the understanding of intestinal homeostasis and the pathogenesis of intestinal diseases.

Indexed as

Cell Culture TechniquesIntestinal MucosaIntestinesOrganoidsAnimalsCell DifferentiationHumansMiceSignal TransductionStem CellsColonFormalin fixed paraffin embeddedHumanImmunostainingIntestinal stem cellsOrganoid monolayerOrganoidsSmall intestine

Identifiers

PMID42763855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.